Research Article
Volume 4 Issue 6 - 2020
Effectiveness of Dipeptidyl Peptidase 4 Inhibitors as Monotherapy and Combination Therapy in Control of Hyperglycemia in Diabetic Patients - An Observational Study Protocol
Saroj Kumar Prusty1, Debmalya Sanyal2* and Sauren Panja3
1Senior Resident, Department of Medicine, NH-RTIICS, Kolkata, India
2Department of Endocrinology, NH-RTIICS and KPC Medical College, Kolkata, India
3Head, Department of Medicine, NH-RTIICS, Kolkata, India
*Corresponding Author: Debmalya Sanyal, Department of Endocrinology, NH-RTIICS and KPC Medical College, Kolkata, India.
Received: April 18, 2020; Published: May 27, 2020




Abstract

The epidemic of type 2 diabetes mellitus worldwide continues without any reduction in intensity. Despite a number of existing therapies, treatment goals are seldom fully achieved. While Insulin resistance and beta cell failure remain important in the pathogenesis of this condition, the role of incretin hormones in glucose homeostasis are becoming more evident. Gliptins inhibit the enzyme dipeptidyl peptidase-4 which degrades incretin hormones by which these drugs control hyperglycemia. This observational study will focus on patients coming to outdoor in medicine and endocrine department. Main emphasis will be early and effective control of hyperglycemia by implementing Gliptins as monotherapy or as combination therapy with metformin. Outcomes will be observed through 3 monthly follow up as per our hospital protocol for diabetic patients by measuring fasting blood sugar (FBS), postprandial blood sugar (PPBS) and glycosylated hemoglobin (HbA1c) level for a period of 9 months. The major goal would be to achieve FBS of less than 130 mg/dl, PPBS of less than 180 mg/dl and a HbA1c of less than 7% in shortest timeline. Emphasis will be given for patients with renal and hepatic impairment while choosing a gliptin by checking serum creatinine, estimated glomerular filtration rate, urine albumin creatinine ratio and serum liver function test. All patients during this study period will be requested and encouraged to do home glucose monitoring.

Keywords: Fasting Blood Sugar (FBS); Postprandial Blood Sugar (PPBS); Glycosylated Hemoglobin (HbA1c)

References

  1. Chahal H and Chowdhury TA. “Gliptins: a new class of oral hypoglycaemic agent”. QJM: An International Journal of Medicine 100 (2007): 671-677.
  2. Barnett A. “DPP-4 inhibitors and their potential role in the management of type 2 diabetes”. International Journal of Clinical Practice 60 (2006): 1454-1470.
  3. Chyan Y and Chuang L. “Dipeptidyl Peptidase-IV Inhibitors: An evolving treatment for type 2 diabetes from the incretin concept”. Recent Patents on Endocrine, Metabolic and Immune Drug Discovery 1 (2007): 15-24.
  4. White JR. “Dipeptidyl peptidase IV inhibitors: Pharmacological profile and clinical use”. Clinical Diabetes 26 (2008): 53-57.
  5. Nauck MA., et al. “Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses”. The Journal of Clinical Endocrinology and Metabolism 63 (1986): 4928.
  6. Barnett A. “DPP-4 inhibitors and their potential role in the management of type 2 diabetes”. International Journal of Clinical Practice 60 (2006): 1454-1470.
  7. Drucker DJ and Nauck MA. “The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes”. Lancet 368 (2006): 1696-1705.
  8. Rosales R., et al. “Effectiveness of vildagliptin and vildagliptin+metformin”. Phillipine Journal of Internal Medicine 54.3 (2016).
  9. Cherbonnel B., et al. “Efficacy and safety of the Dipeptidyl Peptidase-4 inhibitor Sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone”. Diabetes Care 29 (2006): 2638-2643. 
  10. Ristic S., et al. “Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: vildagliptin (LAF237) dose response”. Diabetes, Obesity and Metabolism 7 (2005): 692-698.
  11. Eto T., et al. “Effects of once‐daily teneligliptin on 24‐h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4‐week, randomized, double‐blind, placebo‐controlled trial”. Diabetes, Obesity and Metabolism 14 (2012): 1040-1046. 
  12. Nauck MA., et al. “Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial”. Diabetes, Obesity and Metabolism 9 (2007): 194-205.
Citation: Debmalya Sanyal., et al. “Effectiveness of Dipeptidyl Peptidase 4 Inhibitors as Monotherapy and Combination Therapy in Control of Hyperglycemia in Diabetic Patients - An Observational Study Protocol". EC Nutrition 4.6 (2020): 21-26.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.